Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a43f2e4b8b7b6092fb458f334af73c61 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-46 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-46 |
filingDate |
2016-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_def61c6f3838928fda3c67a5a17e021f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d97e32a3d8f1fd4d761e3409c9971a0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5eba474abd3c95a5e86aa415d46d318 |
publicationDate |
2018-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-3292102-A1 |
titleOfInvention |
Isoindolinones, processes for the production of chiral derivatives thereof and use thereof |
abstract |
The present invention relates the asymmetrical synthesis of heterocyclic compounds of pharmaceutical interest. In particular a series of enantioselective methods is described, allowing the synthesis and transformations of isoindolinones of Formula (I), into high yields and enantiomeric excesses >90%. |
priorityDate |
2015-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |